WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013110354) COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/110354    International Application No.:    PCT/EP2012/061534
Publication Date: 01.08.2013 International Filing Date: 15.06.2012
IPC:
A61K 31/727 (2006.01), A61K 35/28 (2006.01), A61K 35/407 (2006.01), A61K 38/58 (2006.01), A61K 45/06 (2006.01), A61K 9/00 (2006.01), A61P 7/02 (2006.01), A61K 31/5377 (2006.01)
Applicants: UNIVERSITÉ CATHOLIQUE DE LOUVAIN [BE/BE]; Place de l'Université, 1 B-1348 Louvain-La-Neuve (BE) (For All Designated States Except US).
STEPHENNE, Xavier [BE/BE]; (BE) (For US Only).
SOKAL, Etienne [BE/BE]; (BE) (For US Only).
NAJIMI, Mustapha [BE/BE]; (BE) (For US Only).
EECKHOUDT, Stéphane [BE/BE]; (BE) (For US Only).
HERMANS, Cédric [BE/BE]; (BE) (For US Only)
Inventors: STEPHENNE, Xavier; (BE).
SOKAL, Etienne; (BE).
NAJIMI, Mustapha; (BE).
EECKHOUDT, Stéphane; (BE).
HERMANS, Cédric; (BE)
Agent: MICHALÍK, Andrej; De Clercq & Partners E. Gevaertdreef 10a B-9830 Sint-Martens-Latem (BE)
Priority Data:
PCT/EP2012/051157 25.01.2012 EP
Title (EN) COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
(FR) COMPOSITIONS ET PROCÉDÉS DE TRANSPLANTATION DE CELLULES
Abstract: front page image
(EN)The present invention relates to compositions and methods for cell transplantation. In particular, the present invention provides a composition comprising procoagulant cells and at least one factor Xa inhibitor, preferably rivaroxaban, as well as at least one thrombin inhibitor, preferably bivalirudin.
(FR)La présente invention concerne des compositions et des procédés de transplantation de cellules. En particulier, la présente invention concerne une composition comprenant des cellules procoagulantes et au moins un inhibiteur du facteur Xa, de préférence, du rivaroxaban ainsi qu'au moins un inhibiteur de la thrombine, de préférence la bivalirudine.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)